There is insufficient data on Item 9 Labs's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth
5.95%
Revenue growth rate
n/a
Return on equity
n/a
Net Margin
n/a
Last Earnings Update
30 Jun 2023
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Item 9 Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:INLB Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 23
20
-31
18
0
31 Mar 23
20
-31
18
0
31 Dec 22
21
-31
19
0
30 Sep 22
22
-31
19
0
30 Jun 22
24
-22
19
0
31 Mar 22
26
-17
17
0
31 Dec 21
25
-13
15
0
30 Sep 21
22
-11
13
0
30 Jun 21
18
-9
9
0
31 Mar 21
14
-10
7
0
31 Dec 20
10
-11
6
0
30 Sep 20
8
-12
6
0
30 Jun 20
7
-13
5
0
31 Mar 20
6
-12
6
0
31 Dec 19
6
-11
6
0
30 Sep 19
5
-10
5
0
30 Jun 19
4
-2
3
0
31 Mar 19
3
-2
2
0
31 Dec 18
2
-1
1
0
30 Sep 18
1
-1
1
0
30 Sep 17
0
0
0
0
Quality Earnings: Insufficient data to determine if INLB has high quality earnings.
Growing Profit Margin: Insufficient data to determine if INLB's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if INLB's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare INLB's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if INLB's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: INLB has a negative Return on Equity (0%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/10 16:41
End of Day Share Price
2026/05/28 00:00
Earnings
2023/06/30
Annual Earnings
2022/09/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Item 9 Labs Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.